Florence Mavis Brown, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endocrinology | 35 | 2023 | 443 | 10.770 |
Why?
|
Diabetes Mellitus | 36 | 2023 | 5890 | 4.560 |
Why?
|
Reference Standards | 35 | 2023 | 1004 | 3.200 |
Why?
|
Standard of Care | 35 | 2023 | 552 | 3.150 |
Why?
|
Pregnancy in Diabetics | 10 | 2024 | 194 | 2.660 |
Why?
|
Societies, Medical | 36 | 2023 | 3905 | 2.020 |
Why?
|
Diabetes Mellitus, Type 1 | 20 | 2024 | 3454 | 1.920 |
Why?
|
Diabetes, Gestational | 13 | 2024 | 1242 | 1.880 |
Why?
|
Pregnancy Outcome | 8 | 2024 | 2907 | 0.800 |
Why?
|
Blood Glucose | 11 | 2024 | 6379 | 0.710 |
Why?
|
Birth Weight | 7 | 2022 | 2097 | 0.670 |
Why?
|
Retinal Diseases | 2 | 2023 | 702 | 0.650 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2024 | 12289 | 0.630 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 2 | 2013 | 558 | 0.570 |
Why?
|
Hypoglycemic Agents | 7 | 2024 | 3149 | 0.560 |
Why?
|
Diabetes Complications | 3 | 2018 | 1341 | 0.560 |
Why?
|
Pregnancy | 27 | 2024 | 29746 | 0.540 |
Why?
|
Obesity, Morbid | 3 | 2016 | 1287 | 0.500 |
Why?
|
Blood Glucose Self-Monitoring | 4 | 2024 | 457 | 0.480 |
Why?
|
Pregnancy Proteins | 1 | 2013 | 222 | 0.420 |
Why?
|
Hyperglycemia | 2 | 2019 | 1380 | 0.420 |
Why?
|
Fetal Development | 1 | 2018 | 766 | 0.420 |
Why?
|
Health Services | 1 | 2017 | 753 | 0.400 |
Why?
|
Pre-Eclampsia | 2 | 2013 | 1229 | 0.370 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2023 | 2290 | 0.370 |
Why?
|
Adrenal Medulla | 6 | 1990 | 56 | 0.370 |
Why?
|
Insulin | 6 | 2024 | 6596 | 0.340 |
Why?
|
Humans | 80 | 2024 | 760613 | 0.320 |
Why?
|
Pregnancy Complications | 6 | 2017 | 2942 | 0.310 |
Why?
|
Bariatric Surgery | 2 | 2016 | 1005 | 0.300 |
Why?
|
Prenatal Diagnosis | 1 | 2015 | 1264 | 0.300 |
Why?
|
Metabolome | 1 | 2014 | 982 | 0.290 |
Why?
|
Fetal Macrosomia | 2 | 2020 | 131 | 0.280 |
Why?
|
Preconception Care | 2 | 2018 | 139 | 0.260 |
Why?
|
Glucose Tolerance Test | 3 | 2024 | 1174 | 0.260 |
Why?
|
Gastric Bypass | 1 | 2014 | 826 | 0.260 |
Why?
|
Guideline Adherence | 1 | 2015 | 2283 | 0.240 |
Why?
|
Dietary Supplements | 1 | 2017 | 3392 | 0.230 |
Why?
|
Metformin | 2 | 2015 | 912 | 0.220 |
Why?
|
Mass Screening | 2 | 2015 | 5422 | 0.220 |
Why?
|
Lipids | 1 | 2014 | 3336 | 0.220 |
Why?
|
Autoantibodies | 6 | 1991 | 2119 | 0.210 |
Why?
|
Female | 39 | 2024 | 391246 | 0.200 |
Why?
|
Infant, Newborn | 10 | 2020 | 26179 | 0.190 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2006 | 377 | 0.190 |
Why?
|
Comorbidity | 4 | 2023 | 10553 | 0.180 |
Why?
|
Teaching Rounds | 1 | 2024 | 275 | 0.170 |
Why?
|
Climate | 1 | 2020 | 147 | 0.170 |
Why?
|
Adrenocortical Adenoma | 1 | 2000 | 46 | 0.170 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15760 | 0.160 |
Why?
|
Environmental Pollutants | 2 | 2018 | 1265 | 0.160 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2000 | 160 | 0.150 |
Why?
|
Urine | 1 | 2000 | 363 | 0.150 |
Why?
|
Parabens | 1 | 2018 | 114 | 0.150 |
Why?
|
Vaginal Smears | 2 | 2001 | 495 | 0.150 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2023 | 708 | 0.140 |
Why?
|
Postpartum Period | 3 | 2024 | 1168 | 0.140 |
Why?
|
Environmental Exposure | 2 | 2024 | 4412 | 0.140 |
Why?
|
Overweight | 2 | 2020 | 2421 | 0.130 |
Why?
|
Maternal Exposure | 2 | 2024 | 1045 | 0.130 |
Why?
|
Uterine Cervical Dysplasia | 1 | 1999 | 384 | 0.130 |
Why?
|
Nutritional Support | 1 | 2017 | 172 | 0.130 |
Why?
|
Adult | 25 | 2024 | 220007 | 0.120 |
Why?
|
Glyburide | 1 | 2015 | 114 | 0.120 |
Why?
|
Prenatal Care | 2 | 2017 | 1129 | 0.110 |
Why?
|
Papillomaviridae | 1 | 1999 | 1117 | 0.110 |
Why?
|
Phthalic Acids | 1 | 2018 | 476 | 0.110 |
Why?
|
Self Care | 1 | 2018 | 793 | 0.100 |
Why?
|
Soft Tissue Neoplasms | 1 | 2000 | 1152 | 0.100 |
Why?
|
Hospitals | 2 | 2023 | 3928 | 0.100 |
Why?
|
Emigrants and Immigrants | 1 | 2018 | 539 | 0.100 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2014 | 389 | 0.090 |
Why?
|
Body Mass Index | 3 | 2020 | 12914 | 0.090 |
Why?
|
Child | 10 | 2023 | 79799 | 0.090 |
Why?
|
Hypoglycemia | 1 | 2017 | 888 | 0.090 |
Why?
|
Quality Improvement | 2 | 2023 | 3835 | 0.090 |
Why?
|
Sarcoma | 1 | 2000 | 1786 | 0.080 |
Why?
|
Obesity | 3 | 2023 | 12919 | 0.080 |
Why?
|
Islets of Langerhans | 3 | 1989 | 1345 | 0.080 |
Why?
|
Counseling | 1 | 2016 | 1548 | 0.080 |
Why?
|
Catecholamines | 1 | 1989 | 385 | 0.080 |
Why?
|
Infant, Premature | 1 | 2017 | 2092 | 0.080 |
Why?
|
Biopsy | 1 | 1999 | 6771 | 0.070 |
Why?
|
Weight Loss | 2 | 2016 | 2684 | 0.070 |
Why?
|
Twins | 1 | 2009 | 339 | 0.070 |
Why?
|
Adolescent | 11 | 2023 | 87809 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2000 | 2275 | 0.070 |
Why?
|
Autonomic Nervous System | 1 | 1991 | 697 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2020 | 80345 | 0.070 |
Why?
|
Sympathetic Nervous System | 1 | 1989 | 520 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2017 | 1829 | 0.070 |
Why?
|
Posture | 2 | 1989 | 953 | 0.060 |
Why?
|
Prediabetic State | 2 | 1989 | 550 | 0.060 |
Why?
|
Gestational Age | 2 | 2017 | 3564 | 0.060 |
Why?
|
Proteinuria | 1 | 2007 | 594 | 0.060 |
Why?
|
Patient Care Planning | 1 | 2008 | 908 | 0.050 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2005 | 338 | 0.050 |
Why?
|
Boston | 3 | 2024 | 9278 | 0.050 |
Why?
|
Risk Factors | 5 | 2015 | 74333 | 0.050 |
Why?
|
Creatinine | 1 | 2007 | 1904 | 0.050 |
Why?
|
Endocrine Disruptors | 1 | 2024 | 263 | 0.050 |
Why?
|
Infant | 5 | 2017 | 36053 | 0.050 |
Why?
|
Uterine Cervical Diseases | 1 | 2001 | 74 | 0.040 |
Why?
|
Diabetic Foot | 1 | 2024 | 381 | 0.040 |
Why?
|
Prevalence | 1 | 2017 | 15686 | 0.040 |
Why?
|
Ganglia, Sympathetic | 2 | 1990 | 65 | 0.040 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2000 | 135 | 0.040 |
Why?
|
Humidity | 1 | 2020 | 205 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3802 | 0.040 |
Why?
|
Antigens, Nuclear | 1 | 2000 | 184 | 0.040 |
Why?
|
Autoimmune Diseases | 2 | 1990 | 2250 | 0.040 |
Why?
|
Keratins | 1 | 2001 | 497 | 0.040 |
Why?
|
Pregnancy Trimester, First | 2 | 2018 | 908 | 0.040 |
Why?
|
Colposcopy | 1 | 1999 | 150 | 0.040 |
Why?
|
Prognosis | 2 | 2015 | 29661 | 0.040 |
Why?
|
Young Adult | 4 | 2024 | 58748 | 0.040 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1999 | 761 | 0.040 |
Why?
|
Postnatal Care | 1 | 2001 | 260 | 0.040 |
Why?
|
Aged | 9 | 2023 | 169143 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2000 | 418 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 4 | 1990 | 2471 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39262 | 0.040 |
Why?
|
Cervix Uteri | 1 | 2001 | 582 | 0.030 |
Why?
|
Hyaluronic Acid | 1 | 2000 | 482 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 22052 | 0.030 |
Why?
|
Pregnancy Trimester, Second | 1 | 2018 | 732 | 0.030 |
Why?
|
Autoantigens | 1 | 2000 | 877 | 0.030 |
Why?
|
Acarbose | 1 | 2015 | 10 | 0.030 |
Why?
|
Vasodilation | 1 | 1999 | 962 | 0.030 |
Why?
|
Telomerase | 1 | 2000 | 747 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 13308 | 0.030 |
Why?
|
Carcinoma in Situ | 1 | 2000 | 796 | 0.030 |
Why?
|
Male | 10 | 2024 | 359718 | 0.030 |
Why?
|
Temperature | 1 | 2020 | 2221 | 0.030 |
Why?
|
Middle Aged | 10 | 2014 | 220359 | 0.030 |
Why?
|
Reference Values | 2 | 1991 | 4925 | 0.030 |
Why?
|
Insulin Infusion Systems | 1 | 2014 | 217 | 0.030 |
Why?
|
Estrogen Replacement Therapy | 1 | 1999 | 1206 | 0.030 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2000 | 800 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7475 | 0.030 |
Why?
|
Fibrosis | 2 | 1990 | 2042 | 0.030 |
Why?
|
United States | 2 | 2018 | 72448 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2000 | 11070 | 0.030 |
Why?
|
HLA-DR4 Antigen | 1 | 1991 | 29 | 0.030 |
Why?
|
HLA-DR3 Antigen | 1 | 1991 | 33 | 0.030 |
Why?
|
Ganglia, Autonomic | 1 | 1991 | 43 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2000 | 1998 | 0.020 |
Why?
|
Valsalva Maneuver | 1 | 1991 | 99 | 0.020 |
Why?
|
Cohort Studies | 1 | 2014 | 41337 | 0.020 |
Why?
|
New York City | 1 | 2013 | 724 | 0.020 |
Why?
|
Health Behavior | 1 | 2023 | 2622 | 0.020 |
Why?
|
Infant, Small for Gestational Age | 1 | 2013 | 460 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2017 | 833 | 0.020 |
Why?
|
Maternal Age | 1 | 2013 | 807 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2018 | 1725 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2018 | 2326 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1999 | 6065 | 0.020 |
Why?
|
Histocompatibility Testing | 1 | 1991 | 717 | 0.020 |
Why?
|
Adrenal Gland Diseases | 1 | 1990 | 141 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2000 | 2924 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2000 | 5869 | 0.020 |
Why?
|
Infant, Low Birth Weight | 1 | 2013 | 859 | 0.020 |
Why?
|
Staining and Labeling | 2 | 1990 | 1089 | 0.020 |
Why?
|
Pregnancy, Multiple | 1 | 2009 | 215 | 0.020 |
Why?
|
Child, Preschool | 5 | 1991 | 42056 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5877 | 0.020 |
Why?
|
Vagus Nerve | 1 | 1990 | 457 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1999 | 4434 | 0.020 |
Why?
|
Complement System Proteins | 1 | 1990 | 782 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 1 | 1989 | 687 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4035 | 0.020 |
Why?
|
Educational Status | 1 | 2013 | 2514 | 0.020 |
Why?
|
Diabetic Neuropathies | 1 | 1989 | 406 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54306 | 0.020 |
Why?
|
Respiration | 1 | 1991 | 1654 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2000 | 5795 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2000 | 14661 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2000 | 12968 | 0.010 |
Why?
|
Hospitalization | 1 | 2024 | 10789 | 0.010 |
Why?
|
Heart Rate | 2 | 1991 | 4180 | 0.010 |
Why?
|
Lymphocytes | 1 | 1990 | 2611 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 9591 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2000 | 20080 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2000 | 15840 | 0.010 |
Why?
|
Premature Birth | 1 | 2013 | 1770 | 0.010 |
Why?
|
Family | 1 | 1991 | 3189 | 0.010 |
Why?
|
Iontophoresis | 1 | 1999 | 74 | 0.010 |
Why?
|
Nitroprusside | 1 | 1999 | 273 | 0.010 |
Why?
|
Simian virus 40 | 1 | 1979 | 291 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14494 | 0.010 |
Why?
|
Acetylcholine | 1 | 1999 | 629 | 0.010 |
Why?
|
Cell Transformation, Viral | 1 | 1979 | 526 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 1990 | 4742 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1990 | 4938 | 0.010 |
Why?
|
Epithelium | 1 | 2001 | 1605 | 0.010 |
Why?
|
Massachusetts | 1 | 2009 | 8803 | 0.010 |
Why?
|
Teratoma | 1 | 1979 | 403 | 0.010 |
Why?
|
Premenopause | 1 | 1999 | 1038 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 1999 | 978 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1990 | 10181 | 0.010 |
Why?
|
Blood Pressure | 1 | 1989 | 8525 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18413 | 0.010 |
Why?
|
Inflammation | 1 | 1990 | 10755 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1988 | 9185 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 21391 | 0.010 |
Why?
|
Postmenopause | 1 | 1999 | 2509 | 0.010 |
Why?
|
Complement Fixation Tests | 1 | 1989 | 71 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 64981 | 0.000 |
Why?
|
Time Factors | 1 | 1989 | 40139 | 0.000 |
Why?
|
Immunoglobulin A | 1 | 1989 | 978 | 0.000 |
Why?
|
Cell Line | 1 | 1979 | 15620 | 0.000 |
Why?
|
Immunoglobulin M | 1 | 1989 | 1529 | 0.000 |
Why?
|
Plasminogen Activators | 1 | 1979 | 199 | 0.000 |
Why?
|
H-2 Antigens | 1 | 1979 | 358 | 0.000 |
Why?
|
Electrocardiography | 1 | 1990 | 6415 | 0.000 |
Why?
|
Creatine Kinase | 1 | 1979 | 691 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1989 | 4542 | 0.000 |
Why?
|
Clone Cells | 1 | 1979 | 1663 | 0.000 |
Why?
|
Viral Proteins | 1 | 1979 | 1802 | 0.000 |
Why?
|
Cell Division | 1 | 1979 | 4463 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 1990 | 25941 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1979 | 11481 | 0.000 |
Why?
|
Mutation | 1 | 1979 | 29957 | 0.000 |
Why?
|
Mice | 1 | 1979 | 81209 | 0.000 |
Why?
|
Animals | 1 | 1979 | 167960 | 0.000 |
Why?
|